nach oben

Acta Diabetologica

Erschienen in:

04.05.2018 | Review Article

The post-HAPO situation with gestational diabetes: the bright and dark sides

verfasst von: Annunziata Lapolla, Boyd E. Metzger

Erschienen in: Acta Diabetologica | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim

In 2010, in light of the data coming from the HAPO study, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) proposed a new detection strategy and diagnostic criteria for gestational diabetes based on a one-step approach with a 75 g OGTT. This review analyzes and discusses the bright and dark sides of their application.

Methods

The assessment of these recommendations by the international organizations involved in the care of gestational diabetes and a series of observational, retrospective and prospective studies that have been published since 2010 regarding the use of the IADPSG recommendations have been evaluated.

Results

The different international associations involved in the care of pregnancy and of pregnancy complicated by diabetes have not taken an univocal position some of which have accepted them, while others have criticized them. Then, the actual application of the approach recommended by the IADPSG for detecting and diagnosing GDM varies, even at centers that reportedly accept the new diagnostic criteria.

Conclusion

So the challenge lies in making every effort to achieve a global standardization of the strategies for detecting, diagnosing and treating GDM.

American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(suppl 1):S43–S48

Lapolla A, Dalfrà MG, Bonomo M et al (2009) Gestational diabetes mellitus in Italy: a multicenter study. Eur J Obstet Gynecol Reprod Biol 145(2):149–153CrossRefPubMed

Metzger BE, Lowe P, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. New Engl J Med 38:1991–2002

Kim C, Newton KM, Knoop RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes care 25:1862–1868CrossRefPubMed

O’Sullivan JB, Mahan C (1964) Criteria for oral glucose tolerance test in pregnancy. Diabetes 13:436–440CrossRef

Sermer M, Naylor CD, Gare DJ et al (1995) Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 173:146–156CrossRefPubMed

Jensen DM, Damm P, Sørensen B et al (2001) Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 185:413–419CrossRefPubMed

Vambergue A, Nuttens MC, Verier-Mine O et al (2000) Is mild gestational hyperglycaemia associated with maternal and neonatal complications? The Diagest Study. Diabet Med 17:203–208CrossRefPubMed

Lapolla A, Dalfrà MG, Bonomo M et al (2007) Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels? Diabetes Res Clin Pract 77(3):465–470CrossRefPubMed

10.

Lapolla A, Bonomo M, Dalfrà MG et al (2010) Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: a multicentre study. Diabetes Metab 36(4):265–270CrossRefPubMed

11.

HAPO Study Cooperative Research Group, Metzger BE, Lowe LP et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2001CrossRef

12.

Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486CrossRefPubMed

13.

Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348CrossRefPubMedPubMedCentral

14.

Schmidt MI, Duncan BB, Reichelt AJ et al (2001) gestational diabetes mellitus diagnosed with 75 gr glucose tolerance test and adverse pregnancy outcome. Diabetes Care 24:1151–1115CrossRefPubMed

15.

International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentral

16.

Committee Opinion Number 504, American College of Obstetricians and Gynecologists (2011) Screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 118:751–753CrossRef

17.

Ryan EA (2011) Diagnosis of gestational diabetes. Diabetologia 54:480–486CrossRefPubMedPubMedCentral

18.

Long H (2011) Diagnosis of gestational diabetes: can expert opinion replace scientific evidence? Diabetologia 54:2211–2213CrossRefPubMed

19.

Long H, Cundy T (2013) Establishing consensus in the diagnosis of gestational diabetes following HAPO: were do we stand? Curr Diab Res 13:43–50CrossRef

20.

McIntire HD, Metzger BE, Coustan DR et al (2014) Counterpoint: establishing consensus in the diagnosis of gestational diabetes following the HAPO study. Curr Diab Res 14:497–454CrossRef

21.

Sacks DA, Hadden DR, Deerochanawong C et al (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care 35:526–528CrossRefPubMedPubMedCentral

22.

Duran A, Saenz S, Torrejon MJ et al (2014) Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnancy woman: the St. Carlos Gestational Diabetes Study. Diabetes Care 37:2442–2450CrossRefPubMed

23.

Lapolla A, Dalfrà MG, Ragazzi E et al (2011) New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabet Med 28(9):1074–1077CrossRefPubMed

24.

Wery E, Vambergue A, Le Goueff F et al (2014) Impact of the new screening criteria on the gestational diabetes prevalence. J Gynecol Obstet Biol Reprod 43(4):307–313CrossRef

25.

Mayo K, Melamed N, Vandenberghe H et al (2105) The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol 212(2):224–228

26.

Kong JM, Lim K, Thompson DM (2015) Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes 39(2):128–132CrossRefPubMed

27.

Feldman RK, Tieu RS, Yasumura L (2016) Gestational diabetes screening: the international association of the diabetes and pregnancy study groups compared with Carpenter–Coustan screening. Obstet Gynecol 127(1):10–17CrossRef

28.

Ogunleye OK, Davidson KD, Gregg AR, Egerman RS (2017) Perinatal outcomes after adopting 1- versus 2-step approach to diagnosing gestational diabetes. J Matern Fetal Neonatal Med 30(2):186–190CrossRefPubMed

29.

Avalos GE, Owens LA, Dunne F, ATLANTIC DIP Collaborators (2013) Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 36(10):3040–3044CrossRefPubMedPubMedCentral

30.

Donovan LE, Edwards AL, Savu A et al (2017) Population-level Outcomes with a 2-step approach for gestational diabetes screening and diagnosis. Can J Diabetes. https://doi.org/10.1016/j.jcjd.2016.12.010 CrossRefPubMed

31.

Sacks DA, Black MH, Li X, Montoro MN, Lawrence JM (2016) Adverse pregnancy outcomes using the international association of the diabetes and pregnancy study groups criteria: glycemic thresholds and associated risks. Obstet Gynecol 126(1):67–73CrossRef

32.

Waters TP, Dyer AR, Scholtens DM et al (2016) Maternal and neonatal morbidity for woman who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care 39:2204–2210CrossRefPubMedPubMedCentral

33.

Mission JF, Ohno MS, Cheng YW, Caughey AB (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207:326.e1–326.e9CrossRef

34.

Werner EF, Pettker CM, Zuckerwise L et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 35(3):529–535CrossRef

35.

Marseille E, Lohse N, Jiwani A et al (2013) The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med 26(8):802–810CrossRefPubMed

36.

Moses RG, Morris GJ, Petocz P, SanGil F (2011) The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Med J Aust 194(7):338–340PubMed

37.

Agarwal MM, Dhatt GS, Othman Y (2015) Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Compl 29(4):544–549CrossRef

38.

Kalter-Leibovici O, Freedman LS, Olmer L, Lieberman N, Heymann A, Orna T, Lerner-Geva L, Hod M (2012) Screening and diagnosis of gestational diabetes mellitus. Diabetes Care 35:1894–1896CrossRefPubMedPubMedCentral

39.

Savona-Ventura C, Vassallo J, Marre M, Karamanos BG; MGSD-GDM study group (2013) A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women. Int J Gynaecol Obstet 120(3):240–244CrossRefPubMed

40.

Yeral MI, Ozgu-Erdinc AS, Uygur D et al (2014) Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine 46(3):512–518CrossRefPubMed

41.

Poomalar GK, Rangaswamy V (2013) A comparison of fasting plasma glucose and glucose challenge test for screening of gestational diabetes mellitus. J Obstet Gynaecol 33(5):447–450CrossRefPubMed

42.

Ozgu-Erdinc AS, Yilmaz S, Yeral MI et al (2015) Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. J Matern Fetal Neonatal Med 28(16):1957–1962CrossRefPubMed

43.

Wang C, Zhu W, Wei Y et al (2016) The predictive effects of early pregnancy lipid profiles and fasting glucose on the risk of gestational diabetes mellitus stratified by body mass index. J Diabetes Res 2016:3013357

44.

Agarwal MM (2016) Gestational diabetes mellitus: screening with fasting plasma glucose. World J Diabetes 7:279–289CrossRefPubMedPubMedCentral

45.

Agarwal MM, Dhatt GS, Punnose J, Zayed R (2007) Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a high-risk population. J Reprod Med 52(4):299–305PubMed

46.

Corrado F, D’Anna R, Cannata ML et al (2012) Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab 38(5):458–461CrossRefPubMed

47.

Riskin-Mashiah S, Damti A, Younes G, Auslender R (2010) First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 152(2):163–167CrossRefPubMed

48.

Zhu WW, Yang HX, Wei YM et al (2013) Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care 36(3):586–590CrossRefPubMedPubMedCentral

49.

Popova P, Tkachuk A, Dronova A et al (2016) Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol 41(4):477–485PubMed

50.

Jiwani A, Marseille E, Lohse N et al (2012) Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med 25:600–610CrossRefPubMed

51.

Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854CrossRefPubMed

52.

Pintaudi B, Fresa R, Dalfrà M et al (2016) Level of implementation of guidelines on screening and diagnosis of gestational diabetes: a national survey. Diabetes Res Clin Pract 113:48–52CrossRefPubMed

53.

WHO (2013) Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. World Health Organization, Geneva

54.

ACOG (2011) Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol 18(3):751–753

55.

Benhalima K, Van Crombrugge P, Devlieger R et al (2013) Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of Belgium. Diabetol Metab Syndr 5:66–70CrossRefPubMedPubMedCentral

56.

American Diabetes Association (2017) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 40(1):S11–S24CrossRef

57.

NICE Guidelines (2015) Diabetes in pregnancy: management from preconception to the postnatal period. https://www.nice.org.uk/guidance.ng3

58.

Di CianniG, Gualdani E, Berni C, Meucci A, Roti L, Lencioni C, Lacaria E, Seghieri G, Francesconi P (2017) Screening for gestational diabetes in Tuscany, Italy. A population study. Diab Res Clin pract 132:149–156CrossRef

59.

Nielsen KK, De Courten M, Kapur A (2012) The urgent need for universally applicable simple screening procedures and diagnostic criteria for gestational diabetes mellitus-lessons from projects funded by the World Diabetes Foundation. Global Health Action 5:1–12CrossRef

60.

Agarwal MM, Shah SM, Al Kaabi J, Saquib S, Othman Y (2015) Gestational diabetes mellitus: Confusion among medical doctors caused by multiple international criteria. J Obstet Gynaecol Res 41(6):861–869CrossRefPubMed

61.

Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211CrossRefPubMed

Titel: The post-HAPO situation with gestational diabetes: the bright and dark sides
verfasst von: Annunziata Lapolla
Boyd E. Metzger
Publikationsdatum: 04.05.2018
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 9/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-018-1146-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The post-HAPO situation with gestational diabetes: the bright and dark sides

Abstract

Aim

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2018

Choroidal thickness changes in non-treated eyes of patients with diabetes: swept-source optical coherence tomography study

The relationship between sleep and cognitive function in patients with prediabetes and type 2 diabetes

Reply to Dereke, J., Hillman, M. “The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review” Acta Diabetol (2017) 54:885. https://doi.org/10.1007/s00592-017-1026-6

Physical activity during pregnancy is associated with a lower prevalence of gestational diabetes mellitus in Vietnam

Aerobic training improves platelet function in type 2 diabetic patients: role of microRNA-130a and GPIIb

Association of branched chain amino acids related variant rs1440581 with risk of incident diabetes and longitudinal changes in insulin resistance in Chinese

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin